Alcoholic Hepatitis Epidemiology Forecast to 2030 - Current Available Treatments - ResearchAndMarkets.com

·5-min read

The "Alcoholic Hepatitis - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

This report delivers an in-depth understanding of the disease, historical, and forecasted Alcoholic Hepatitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

The Alcoholic Hepatitis epidemiology report gives a thorough understanding of Alcoholic Hepatitis by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Alcoholic Hepatitis in the US and Europe. Moreover, the report covers the Alcoholic Hepatitis scenario's detailed information in seven major countries (US, EU5, and Japan).

Epidemiology Perspective

This section encompassing Alcoholic Hepatitis epidemiology provides insights about historical and current patient pool and forecasted trends for every seven major countries. The Alcoholic Hepatitis epidemiology data are studied through all possible divisions to better understand the disease scenario in 7MM. This segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports, and views of key opinion leaders.

Detailed Epidemiology Segmentation

The Alcoholic Hepatitis epidemiology covered in the report provides historical as well as forecasted Alcoholic Hepatitis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

Report Highlights

  • 11-year Forecast of Alcoholic Hepatitis Epidemiology

  • 7MM Coverage

  • Total Prevalent cases of Alcoholic Hepatitis

  • Diagnosed Cases of Alcoholic Hepatitis

  • Severity-specific Cases of Alcoholic Hepatitis

  • Gender-specific Cases of Alcoholic Hepatitis

KOL - Views

We interview KOLs and include SME's opinion through primary research to fill the data gaps and validate the secondary research. The view helps understand the total patient population and current treatment pattern. It will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM concerning the patient population pertaining to Alcoholic Hepatitis?

  • What are the key findings pertaining to the Alcoholic Hepatitis epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2017-2030)?

  • What would be the total number of patients of Alcoholic Hepatitis across the 7MM during the forecast period (2017-2030)?

  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?

  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?

  • What are the disease risks, burdens, and unmet needs of Alcoholic Hepatitis?

  • What are the currently available treatments of Alcoholic Hepatitis?

Reasons to Buy

The Alcoholic Hepatitis Epidemiology report will allow the user to:

  • Develop business strategies by understanding the trends shaping and driving the global Alcoholic Hepatitis market.

  • Quantify patient populations in the global Alcoholic Hepatitis market to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Alcoholic Hepatitis therapeutics in each of the markets covered.

  • Understand the magnitude of the Alcoholic Hepatitis population by its epidemiology.

  • The Alcoholic Hepatitis Epidemiology Model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over an 11-year forecast period using reputable sources.

Key Topics Covered:

1. Key Insights

2. Executive Summary of Alcoholic Hepatitis

3. SWOT Analysis for Alcoholic Hepatitis

4. Alcoholic Hepatitis: Disease Overview

4.1. Introduction

4.2. Alcoholic Liver Disease

4.3. Etiology

4.4. Signs and Symptoms

4.5. Clinical Presentation

4.6. Histopathology

4.7. Pathogenesis

4.8. Prognosis

4.9. Risk Factors

4.10. Diagnosis

4.10.1. Differential Diagnosis

5. Epidemiology and Patient Population

5.1. Key Findings

6. 7MM Epidemiology

6.1. Assumptions and rationale

6.2. Diagnosed Moderate to Severe Cases of Alcoholic Hepatitis (AH) in 7MM

6.3. United States

6.4. Germany

6.5. France

6.6. Italy

6.7. Spain

6.8. United Kingdom

6.9. Japan

7. Treatment of Alcoholic Hepatitis

8. Unmet Needs

9. Organizations contributing toward AH

10. Case studies

10.1. Alcoholic hepatitis - the case for intensive management

10.2. Case of severe alcoholic hepatitis treated with granulocytapheresis

10.3. Severe Alcoholic Hepatitis: Atypical Presentation with Markedly Elevated Alkaline Phosphatase

10.4. Alcoholic Hepatitis with an Unexpected Histology: A Case Report

11. KOL Views

12. Appendix

12.1. Report Methodology

12.2. References

13. Publisher Capabilities

14. Disclaimer

15. About the Publisher

For more information about this report visit https://www.researchandmarkets.com/r/epsu4u

View source version on businesswire.com: https://www.businesswire.com/news/home/20201203005659/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900